Canaccord Genuity Group Trims Evolent Health (NYSE:EVH) Target Price to $44.00

Evolent Health (NYSE:EVHGet Free Report) had its price target reduced by Canaccord Genuity Group from $45.00 to $44.00 in a note issued to investors on Thursday, Benzinga reports. The firm currently has a “buy” rating on the technology company’s stock. Canaccord Genuity Group’s target price points to a potential upside of 34.19% from the stock’s previous close.

Several other brokerages also recently issued reports on EVH. Oppenheimer assumed coverage on shares of Evolent Health in a research report on Friday, March 1st. They set an “outperform” rating and a $45.00 price objective for the company. William Blair reissued an “outperform” rating on shares of Evolent Health in a research report on Tuesday, January 9th. JPMorgan Chase & Co. lowered their price objective on shares of Evolent Health from $53.00 to $52.00 and set an “overweight” rating for the company in a research report on Friday, March 15th. Barclays assumed coverage on shares of Evolent Health in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $39.00 price objective for the company. Finally, JMP Securities increased their price objective on shares of Evolent Health from $37.00 to $38.00 and gave the stock a “market outperform” rating in a research report on Friday, February 23rd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Evolent Health currently has an average rating of “Moderate Buy” and a consensus price target of $42.70.

Get Our Latest Analysis on Evolent Health

Evolent Health Stock Up 0.2 %

Shares of NYSE:EVH opened at $32.79 on Thursday. Evolent Health has a 52 week low of $23.33 and a 52 week high of $36.70. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market capitalization of $3.78 billion, a PE ratio of -25.82 and a beta of 1.54. The company has a 50 day moving average price of $31.93 and a two-hundred day moving average price of $29.79.

Evolent Health (NYSE:EVHGet Free Report) last issued its earnings results on Thursday, February 22nd. The technology company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.02 by $0.13. Evolent Health had a negative net margin of 5.76% and a positive return on equity of 6.60%. The firm had revenue of $556.06 million during the quarter, compared to the consensus estimate of $541.87 million. Analysts forecast that Evolent Health will post 0.87 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the business. West Tower Group LLC lifted its stake in Evolent Health by 656.4% in the fourth quarter. West Tower Group LLC now owns 885 shares of the technology company’s stock valued at $29,000 after acquiring an additional 768 shares during the last quarter. ICA Group Wealth Management LLC acquired a new stake in Evolent Health in the fourth quarter valued at $33,000. Signaturefd LLC lifted its stake in Evolent Health by 1,470.7% in the fourth quarter. Signaturefd LLC now owns 1,445 shares of the technology company’s stock valued at $48,000 after acquiring an additional 1,353 shares during the last quarter. Captrust Financial Advisors lifted its stake in Evolent Health by 254.4% in the second quarter. Captrust Financial Advisors now owns 1,758 shares of the technology company’s stock valued at $54,000 after acquiring an additional 1,262 shares during the last quarter. Finally, NBC Securities Inc. acquired a new stake in Evolent Health in the fourth quarter valued at $69,000.

Evolent Health Company Profile

(Get Free Report)

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.

Read More

Analyst Recommendations for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.